Geis-Hides Consulting guides pharmaceutical and biotechnology companies through the FDA process. We have a strong track record delivering successful clinical development plans, trial designs, and operational strategies. At the center of our success is the diligent creation of the CDP (Clinical Development Plan). Consultation is offered at pre-clinical, clinical, and post-clinical phases. The team is led by Dr. Steve Geis MD, PhD, who served as Global Vice-President for Arthritis, Cardiovascular, and Oncology at Pharmacia. He established strategies that led to the development of Celebrex as well as 5 other marketed drugs. The Geis-Hides approach is fundamental yet unique and is applicable to all therapeutic areas. Risk mitigation and creation of efficiencies are paramount themes. Our areas of expertise include Osteoarthritis, Rheumatology, Gastrointestinal, Oncology, Hematology, and Cardiovascular.